Abstract
11P Independent validation of the HER2DX assay in HER2-positive (HER2+) breast cancer (BC) treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): A correlative analysis from the BiOnHER study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have